Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK on OTC ads

This article was originally published in The Tan Sheet

Executive Summary

Guidelines for advertisements promoting OTCs for previously restricted indications are expected by year-end, UK's Medicines & Healthcare Products Regulatory Agency announces Aug. 11. Under the new guidelines, aspirin may be promoted for secondary prevention of heart attacks, while calcium and vitamin D products may be touted to prevent osteoporosis. Agency proposed amending the 1994 regulations in a November 2002 consultation letter (1"The Tan Sheet" Nov. 11, 2002, p. 17). Forty-one comments were received, of which 13 opposed removal of the restrictions and 31 supported the initiative...

You may also be interested in...



Aspirin Ad Claims For Cardiovascular Benefits Allowed In UK Proposal

Promoting aspirin 75 mg to consumers for secondary prevention of heart attack or stroke would be permitted in the UK under a proposal issued for consultation by the country's Medicines Control Agency Nov. 4

Individualized Gene Therapy: US FDA Considering Device-Like Manufacturing Approval Process

CBER Director Peter Marks said the agency could streamline development by allowing sponsors to depend on an already-approved manufacturing platform and reviewing any modifications that are proposed.

Faulty CDC COVID-19 Assays Leave Only 12 US Jurisdictions With Testing Ability, CDC Director Says

Only 12 US jurisdictions currently have sound COVID-19 virus assays from the Centers for Disease Control and Prevention to test suspected virus cases, CDC director Robert Redfield told a House panel looking at virus preparedness on Wednesday – but a better batch is coming, he said. Other questions raised at the congressional hearing was how long an infected person stays infected, whether COVID-19 can be picked up from inanimate surfaces, and related queries.

Topics

UsernamePublicRestriction

Register

PS095827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel